Endpoint definition
↥| Name | RX_CROHN_2NDLINE |
|---|---|
| Long name | Second line medication for Crohns disease |
| Medicine purchases: ATC codes | L04AX|L01BB02 |
| First defined in version | DF5 |
| Name | RX_CROHN_2NDLINE |
|---|---|
| Long name | Second line medication for Crohns disease |
| Medicine purchases: ATC codes | L04AX|L01BB02 |
| First defined in version | DF5 |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 9669 | 6017 | 3652 |
| Unadjusted prevalence (%) | 4.46 | 4.90 | 3.88 |
| Mean age at first event (years) | 51.09 | 50.40 | 52.22 |
| Case fatality at 5-years (%) | 1.85 | 1.36 | 2.66 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 10.0 | 10.0 | 10.0 |
| Recurrence at 6 months (%) | 86.82 | 86.94 | 86.63 |
before Second line medication for Crohns disease
after Second line medication for Crohns disease
Loading survival analyses plot…
Loading survival analyses table…